LEADER 03320namaa2200973uu 4500
001 doab98158
003 oapen
005 20230307
006 m o d
007 cr|mn|---annan
008 230307s2023 xx |||||o ||| 0|eng d
020 |a 9783036568362 
020 |a 9783036568379 
020 |a books978-3-0365-6836-2 
024 7 |a 10.3390/books978-3-0365-6836-2  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a K  |2 bicssc 
720 1 |a Dedieu, Stephane  |4 edt 
720 1 |a Dedieu, Stephane  |4 oth 
245 0 0 |a Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 online resource (206 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a Despite major medical advances in recent decades, colorectal cancer remains a major public health problem with significant unmet medical needs. This reprint presents new scientific and clinical data, and discusses the need to identify new theranostic biomarkers from tissue and fluid biopsies, to go further in terms of personalised medicine and thus overcome current limitations. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Economics, Finance, Business and Management  |2 bicssc 
653 |a ablation 
653 |a ACKR3 
653 |a adjuvant 
653 |a chemokine 
653 |a chemotherapy 
653 |a circulating tumor cells 
653 |a CMS 
653 |a colon cancer 
653 |a colonic neoplasms 
653 |a colorectal cancer 
653 |a discoidin domain receptor 
653 |a dual expression 
653 |a early recurrence 
653 |a epigenetics 
653 |a ERBB2 
653 |a event free survival 
653 |a extracellular vesicles 
653 |a genome-wide association study 
653 |a HER-2 
653 |a heterogeneity 
653 |a high-definition single-cell assay 
653 |a liquid biopsy 
653 |a liver metastases 
653 |a lung metastases 
653 |a Lynch Syndrome 
653 |a Mendelian randomization 
653 |a metastasis 
653 |a microenvironment 
653 |a mismatch repair proteins 
653 |a multi-assay 
653 |a n/a 
653 |a oncosomes 
653 |a PD-L1 
653 |a polygenic risk scores 
653 |a poor prognosis 
653 |a pre-metastatic niche 
653 |a precision medicine 
653 |a prognosis 
653 |a protein biomarker 
653 |a rare cell 
653 |a RAS mutations 
653 |a resection 
653 |a resistance 
653 |a signaling pathways 
653 |a Snail transcription factor 
653 |a surgery 
653 |a survival 
653 |a therapy 
653 |a tumor budding 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/98158  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/6931  |7 0  |z Open Access: DOAB, download the publication